Sees FY26 revenue up mid-to-high single-digit percentage.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca posts strong Q1 2026 growth and doubles down on high-value pipeline
- FDA Recruits AstraZeneca, Amgen in Bet on AI to Accelerate Drug Development
- Overhang should lift for Guardant after AstraZeneca AdCom, says Leerink
- Guardant falls after FDA briefing documents for camizestrant
- FDA turning to AI to speed up clinical trials, WSJ reports